BRCA2 and breast carcinoma: While most breast cancers carrying BRCA1 mutations undergo loss-of-heterozygosity (LOH) of their wild-type allele as their second hit, BRCA1 and BRCA2 promoter methylation have also been detected in some tumors without LOH [104, 127, 128].